FDA Inspection 911142 — Sciegen Pharmaceuticals Inc

Sciegen Pharmaceuticals Inc — FEI 3008298016

The FDA completed an inspection of Sciegen Pharmaceuticals Inc on Jan 9, 2015 in Hauppauge, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 9, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Hauppauge, NY (United States)

Additional details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.